223 related articles for article (PubMed ID: 18647205)
41. Disappearance of p27(KIP1) and increase in proliferation of the lens cells after extraction of most of the fiber cells of the lens.
Kase S; Yoshida K; Ikeda H; Harada T; Harada C; Imaki J; Ohgami K; Shiratori K; Nakayama KI; Nakayama K; Ohno S
Curr Eye Res; 2005 Jun; 30(6):437-42. PubMed ID: 16020276
[TBL] [Abstract][Full Text] [Related]
42. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
43. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
[TBL] [Abstract][Full Text] [Related]
45. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
[TBL] [Abstract][Full Text] [Related]
46. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
[TBL] [Abstract][Full Text] [Related]
47. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
[TBL] [Abstract][Full Text] [Related]
48. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70.
Zou P; Yoshihara H; Hosokawa K; Tai I; Shinmyozu K; Tsukahara F; Maru Y; Nakayama K; Nakayama KI; Suda T
Cell Stem Cell; 2011 Sep; 9(3):247-61. PubMed ID: 21885020
[TBL] [Abstract][Full Text] [Related]
49. Expression of p-27 (kip1) in nevi and melanomas.
Morgan MB; Cowper SE
Am J Dermatopathol; 1999 Apr; 21(2):121-4. PubMed ID: 10218670
[TBL] [Abstract][Full Text] [Related]
50. Expression of p57-Kip2 in monocytes and macrophages.
Hofer TP; Frankenberger M; Staples KJ; Ziegler-Heitbrock L
Immunobiology; 2006; 211(6-8):455-62. PubMed ID: 16920485
[TBL] [Abstract][Full Text] [Related]
51. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
52. Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma.
Strömberg S; Agnarsdóttir M; Magnusson K; Rexhepaj E; Bolander A; Lundberg E; Asplund A; Ryan D; Rafferty M; Gallagher WM; Uhlen M; Bergqvist M; Ponten F
J Proteome Res; 2009 Apr; 8(4):1639-46. PubMed ID: 19714869
[TBL] [Abstract][Full Text] [Related]
53. Involvement of p27KIP1 in the proliferation of the developing corneal endothelium.
Yoshida K; Kase S; Nakayama K; Nagahama H; Harada T; Ikeda H; Harada C; Imaki J; Ohgami K; Shiratori K; Ilieva IB; Ohno S; Nishi S; Nakayama KI
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2163-7. PubMed ID: 15223790
[TBL] [Abstract][Full Text] [Related]
54. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
55. Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies.
Hoffner L; Parks WT; Swerdlow SH; Carson JC; Surti U
J Reprod Med; 2010; 55(5-6):219-28. PubMed ID: 20626178
[TBL] [Abstract][Full Text] [Related]
56. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.
Keller-Melchior R; Schmidt R; Piepkorn M
J Invest Dermatol; 1998 Jun; 110(6):932-8. PubMed ID: 9620301
[TBL] [Abstract][Full Text] [Related]
57. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions.
Ivan D; Diwan AH; Esteva FJ; Prieto VG
Mod Pathol; 2004 Jul; 17(7):811-8. PubMed ID: 15154004
[TBL] [Abstract][Full Text] [Related]
58. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
[TBL] [Abstract][Full Text] [Related]
59. IGFBP7 is not required for B-RAF-induced melanocyte senescence.
Scurr LL; Pupo GM; Becker TM; Lai K; Schrama D; Haferkamp S; Irvine M; Scolyer RA; Mann GJ; Becker JC; Kefford RF; Rizos H
Cell; 2010 May; 141(4):717-27. PubMed ID: 20478260
[TBL] [Abstract][Full Text] [Related]
60. p57(KIP2) regulates radial glia and intermediate precursor cell cycle dynamics and lower layer neurogenesis in developing cerebral cortex.
Mairet-Coello G; Tury A; Van Buskirk E; Robinson K; Genestine M; DiCicco-Bloom E
Development; 2012 Feb; 139(3):475-87. PubMed ID: 22223678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]